Ibudilast, a phosphodiesterase inhibitor with anti-inflammatory activity, protects against ischemic brain injury in rats

Armstead, 1988, The role of prostanoids in the mediation of responses to KC-404, a novel cerebrovasodilator, J. Pharmacol. Exp. Ther., 244, 138 Barkhof, 2010, Ibudilast in relapsing-remitting multiple sclerosis: a neuroprotectant?, Neurology, 74, 1033, 10.1212/WNL.0b013e3181d7d651 Bederson, 1986, Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination, Stroke, 17, 472, 10.1161/01.STR.17.3.472 Caso, 2007, Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke, Circulation, 115, 1599, 10.1161/CIRCULATIONAHA.106.603431 Cho, 2010, Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast, Proc. Natl. Acad. Sci. U. S. A., 107, 11313, 10.1073/pnas.1002716107 Fisher, 2011, New approaches to neuroprotective drug development, Stroke, 42, S24, 10.1161/STROKEAHA.110.592394 Fishman, 1975, Brain edema, N. Eng. J. Med., 293, 706, 10.1056/NEJM197510022931407 Fukuyama, 1993, Pharmacological effects of ibudilast on cerebral circulation: a PET study, Neurol. Res., 15, 169, 10.1080/01616412.1993.11740130 Gibson, 2006, The inhibitory profile of ibudilast against the human phosphodiesterase enzyme family, Eur. J. Pharmacol., 538, 39, 10.1016/j.ejphar.2006.02.053 Gladstone, 2002, Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions, Stroke, 33, 2123, 10.1161/01.STR.0000025518.34157.51 Huang, 2006, Preferential inhibition of human phosphodiesterase 4 by ibudilast, Life Sci., 78, 2663, 10.1016/j.lfs.2005.10.026 Hutchinson, 2008, Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4), Eur. J. Neurosci., 28, 20, 10.1111/j.1460-9568.2008.06321.x Hutchinson, 2009, Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast), Brain Behav. Immun., 23, 240, 10.1016/j.bbi.2008.09.012 Jander, 2007, Imaging inflammation in acute brain ischemia, Stroke, 38, 642, 10.1161/01.STR.0000250048.42916.ad Jin, 2010, Inflammatory mechanisms in ischemic stroke: role of inflammatory cells, J. Leukoc. Biol., 87, 779, 10.1189/jlb.1109766 Kagitani-Shimono, 2005, Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model, J. Neuroinflammation, 2, 10, 10.1186/1742-2094-2-10 Kishi, 2001, Ibudilast: A non-selective PDE inhibitor with multiple actions on blood cells and the vascular wall, Cardiovasc. Drug. Rev., 19, 215, 10.1111/j.1527-3466.2001.tb00066.x Ledeboer, 2006, The glial modulatory drug AV411 attenuates mechanical allodynia in rat models of neuropathic pain, Neuron Glia Biol., 2, 279, 10.1017/S1740925X0700035X Longa, 1989, Reversible middle cerebral artery occlusion without craniectomy in rats, Stroke, 20, 84, 10.1161/01.STR.20.1.84 Meyer, 1979, A method for the routine assessment of fore- and hindlimb grip strength of rats and mice, Neurobehav. Toxicol., 1, 233 Mizuno, 2004, Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia, Neuropharmacology, 46, 404, 10.1016/j.neuropharm.2003.09.009 Onoue, 1992, The potentiating effect of KC-404 on prostacyclin-induced vasodilation in isolated human cerebral artery, Gen. Pharmacol., 23, 1093, 10.1016/0306-3623(92)90292-R Reglodi, 2003, Examination of sensorimotor performance following middle cerebral artery occlusion in rats, Brain Res. Bull., 59, 459, 10.1016/S0361-9230(02)00962-0 Rile, 2001, Potentiation of ibudilast inhibition of platelet aggregation in the presence of endothelial cells, Thromb. Res., 102, 239, 10.1016/S0049-3848(01)00258-4 Sanz, 2005, PDE-4 inhibitors as new anti-inflammatory drugs: effects on cell trafficking and cell adhesion molecules expression, Pharmacol. Ther., 106, 269, 10.1016/j.pharmthera.2004.12.001 Souness, 1994, Possible role of cyclic AMP phosphodiesterases in the actions of ibudilast on eosinophil thromboxane generation and airways smooth muscle tone, Br. J. Pharmacol., 111, 1081, 10.1111/j.1476-5381.1994.tb14855.x Spina, 2008, PDE4 inhibitors: current status, Br. J. Pharmacol., 155, 308, 10.1038/bjp.2008.307 Suzumura, 1999, Ibudilast suppresses TNF-α production by glial cells functioning mainly as type III phosphodiesterase inhibitor in the CNS, Brain Res., 837, 203, 10.1016/S0006-8993(99)01666-2 Takuma, 2001, Anti-apoptotic effect of cGMP in cultured astrocytes: inhibition by cGMP-dependent protein kinase of mitochondrial permeable transition pore, J. Biol. Chem., 276, 48093, 10.1074/jbc.M108622200 Tominaga, 1996, Ibudilast protects against neuronal damage induced by glutamate in cultured hippocampal neurons, Clin. Exp. Pharmacol. Physiol., 23, 519, 10.1111/j.1440-1681.1996.tb02772.x Wakita, 2003, Ibudilast, a phosphodiesterase inhibitor, protects against white matter damage under chronic cerebral hypoperfusion in the rat, Brain Res., 992, 53, 10.1016/j.brainres.2003.08.028 Walters, 2003, Transient ischaemic attacks are associated with increased rates of global cerebral atrophy, J. Neurol. Neurosurg. Psychiatry, 74, 213, 10.1136/jnnp.74.2.213 Yoshioka, 1998, Cyclic AMP-elevating agents prevent oligodendroglial excitotoxicity, J. Neurochem., 70, 2416, 10.1046/j.1471-4159.1998.70062416.x Yoshioka, 2000, Cyclic GMP/cyclic GMP-dependent protein kinase system prevents excitotoxicity in an immortalized oligodendroglial cell line, J. Neurochem., 74, 633, 10.1046/j.1471-4159.2000.740633.x Yoshioka, 2002, Effects of ibudilast on hippocampal long-term potentiation and passive avoidance responses in rats with transient cerebral ischemia, Pharmacol. Res., 45, 305, 10.1006/phrs.2002.0949 Zipp, 2006, The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases, Trends Neurosci., 29, 518, 10.1016/j.tins.2006.07.006